Vinod Labhasetwar

Vinod Labhasetwar, PhD, is a Professor at the Cleveland Clinic Lerner College of Medicine and Staff in the Department of Biomedical Engineering at the Lerner Research Institute. He serves as Director of the Cancer Nanomedicine Program and leads pioneering research in nanomedicine for cancer, cardiovascular diseases, and CNS injuries. His work spans translational applications, including drug delivery, epigenetic therapy, and neuroprotection.

• Professor, Cleveland Clinic Lerner College of Medicine
• Staff, Biomedical Engineering, Lerner Research Institute
• Director, Cancer Nanomedicine Program

Dr. Labhasetwar’s laboratory focuses on nanotechnology for treating drug-resistant cancers, metastasis, stroke, spinal cord injuries, and retinal degeneration. Key projects include:

• Epigenetic nanotherapy for breast cancer stem cells
• Neuroprotective nanoparticles to prevent reperfusion injury
• Balloon-based nanocarrier delivery for peripheral artery disease
• Biophysical approaches to tumor drug resistance

Recent publications highlight nanocarrier design for stroke, bone metastasis, and spinal cord repair, with funding from NIH and Department of Defense. His team has generated over 20 patents in nanomedicine. Current work explores dual-action nanoparticle therapies and biophysical mechanisms of cellular uptake.